Price (delayed)
$120.76
Market cap
$14.7B
P/E Ratio
58.06
Dividend/share
$0.28
EPS
$2.08
Enterprise value
$16.78B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.